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This study was conducted to determine if the behavioral asymmetry associated with unilateral nigrostriatal dopamine (DA) depletion could 
be alleviated by placing a small DA-releasing silicone polymer matrix pellet into the denervated striatum of rats. Animals that received 
DA-releasing pellets showed a 50% reduction in apomorphine-induced rotational behavior, and this effect persisted for the 2-month duration 
of the experiment. The results suggest that the controlled release of DA from an intrastriatal polymer matrix can produce a long-lasting 
reduction in some of the symptons associated with DA depletion. 
INTRODUCTION 
Rats with a large unilateral lesion of the nigrostriatal 
dopamine (DA)  system show behavioral asymmetries 
similar to those seen in people with hemi-Parkinsonism, 
and these behavioral asymmetries are accentuated by 
t rea tment  with D A  agonists 18'19. For example, the direct- 
acting D A  receptor agonist, apomorphine (APO),  causes 
animals to turn in circles contralateral to the lesion side 
due to the action of A P O  at supersensitive D A  receptors 
in the denervated striatum 4'18'19. Grafts of DA-con-  
taining tissue (either fetal substantia nigra or adrenal 
medulla  tissue) in or near the denervated striatum reduce 
the D A  receptor supersensitivity, an effect that is 
manifest  as a decrease in APO-induced  turning be- 
havior 6"7'9-11'14. 
The mechanism through which tissue grafts induce 
their behavioral  effect is still unknown.  One possibility is 
that tissue grafts alleviate the behavioral asymmetry 
produced by unilateral D A  depletion by simply providing 
a supplementary source of DA.  If this is the case, it may 
be possible to produce a similar restoration of function by 
providing the striatum with D A  through alternative 
means. 
The present experiment  was designed as a preliminary 
test of this hypothesis. D A  was provided via a small 
DA-si l icone polymer pellet that slowly and continuously 
released DA.  It is reported that placement  of a DA-  
releasing pellet into the denervated striatum of rats with 
a unilateral nigrostriatal D A  lesion reduced APO-evoked  
rotational behavior by 50% for the 2-month durat ion of 
the experiment.  
MATERIALS AND METHODS 
Intrastriatal DA-silicone matrix implants 
The DA-silicone matrix was prepared by mixing 20 parts of DA 
hydrochloride in 80 parts of polymethyisiloxane monomer (Silastic 
382, Dow Corning, Midland, MI) with stannous octanoate as 
catalyst, using procedures similar to those previously de- 
scribedlZ.The mixture was molded into strips 1 cm wide and 1 mm 
thick and cured at room temperature. Control implant material was 
prepared in the same way, but did not contain DA. Pellets for 
implantation were made by punching 1-mm diameter pieces from 
the polymer strip with a stainless-steel punch, and then incubating 
the pellets for 18-24 h in 0.9% saline at 37 °C. Individual pellets 
weighed 0.64 + 0.05 mg prior to incubation. Some pellets were 
placed into the striatum in one piece, and others were cut in half and 
placed at two sites within the striatum, as described below. 
DA release from silicone matrix implants 
In vitro experiments were conducted to estimate the rate of DA 
release from the silicone polymer matrix. Pellets of DA-containing 
polymer 1 mm diameter (n = 5) were incubated in 0.05 M potassium 
phosphate buffer with 10 mM Na2S205, pH 7.4 at 37 °C. Incubation 
was conducted in 1.5 ml plastic-capped tubes. When these tubes 
were completely filled with buffer and tightly capped, no  DA 
oxidation was observed. The incubation solutions were changed at: 
1, 2, 3, 6, 7, 10, 14, 21, 28, 35, 42 and 56 days; The solubilized DA 
released from the pellets was monitored by HPLC-EC as previously 
Correspondence." J.B. Becker, Neuroscience Laboratory Building, 1103 East Huron St., Ann Arbor, MI 48104-1687, U.S.A. 
0006-8993/90/$03.50 © 1990 Elsevier Science Publishers B.V. (Biomedical Division) 
described ~6 and the rate of  D A  release from the matrix was 
de te rmined  over the 7-week time period. In separate  experiments ,  
1 cm 2 pieces (n = 4) were incubated in 9 ml buffer. D A  release from 
the matrix in these exper iments  was quantified by absorbance at 279 
nm at 1, 2, 3, 6 and 24 h and at 2, 3, 6, 7, 10, 14, 21, 35 and 42 days 
of incubation.  
Subjects and experimental procedures 
Male Hol tzman rats (Madison,  WI; n = 23) weighing 20(l-250 g 
received a unilateral 6-hydroxydopamine lesion of the substantia 
nigra, as previously described ~~('. Beginning 2 weeks after the 
lesion all animals were tested for baseline rates of  APO-induced  
rotational behavior  (0.25 mg/kg, s.c.) in au tomated  rotometers  ~5, 
Each rat was tested 2-3  times, with 3 days between tests. Only rats 
that  made  more than 90 full rotations (360 ° turns) during at least two 
of the 40-min test sessions were included in the study. Animals  that 
meet  this criteria invariably have a >90% striatal D A  depletion. 
Ten days after the last baseline test each animal was anesthetized 
with sodium pentobarbi tal  supplemented  with methoxyflurane.  
Using s tandard stereotaxic techniques and aseptic surgical proce- 
dures,  one or two small pellets of  the s i l icone-polymer matrix were 
placed into the denervated  str iatum of each animal using a trocar 
device constructed in the laboratory (coordinates (from Bregma,  
with Bregma and Lambda  horizontal),  single pellet: AP +0.5 mm.  
L 2.8 mm,  V 6.0 mm;  two pellets: (a) AP  -0 .26 mm,  L 3.0 mm,  V 
5.5 ram; and (b) AP  +1.2 mm,  L 2.5 ram, V 5.5 ram). Following 
surgery the animals were re turned to their home cages and left 
undis turbed until retested for APO-induced  rotational behavior 1. 
3, 10, 30 and 60 days later. 
At  the complet ion of the behavioral exper iment  the animals were 
perfused with 0 .9% saline followed by 10% formalin. The brains 
were removed and stored in 1()~; formalin until frozen sections (4(I 
,~m thick) were obtained.  The  location of the pellets within the brain 
was de te rmined  by examinat ion of Cresyl violet-stained sections. 
Four animals were excluded because their pellets were not in the 
intended location. 
RESULTS 
The rate of DA release from the silicone matrix in 
vitro was not dramatically influenced by the shape/size of 
the matrix. As can be seen in Fig. 1, with both 
configurations of the matrix there is a very rapid release 
of DA during the first 24 h in vitro. The DA-silicone 
polymer matrix pellets used in the behavioral exper- 
iments released approximately 373.6 + 20.0 nmol DA/ 
pellet (mean _+ S.E.M.) or about 55% of the DA 
contained in the pellet during this period prior to 
implantation. Between days 1 and 10 in vitro, the pellets 
released an additonal 37% of the total DA. Between days 
10 and 60, DA release continued to decrease. A total of 
1.69 + 0.13 nmol DA/pellet or 2.5% was released during 
this period of time in vitro. Release of DA from the 
larger pieces of DA-silicone matrix was slightly less 
during the initial dynamic phase of DA release, but the 
profile of the time course is quite similar (Fig. 1). It must 
be stressed, however, that how well release rate in vitro 
approximates release in vivo is not known. 
Both control and experimental animals showed a 
marked, but transient, reduction in APO-induced turning 
behavior 1-3 days after implantation of the polymer 
pellets. The reduction was significantly greater, however, 
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Fig. l. Cumulat ive D A  release (nmol D A / m g  polymer)  from l-ram 
diameter  DA-s i l i cone  polymer matrix pellets (open squares;  n - 5) 
or 1 cm e pieces (closed squares;  n - 4) during incubation in vitro 
(see text for additional details). 
in animals with DA-releasing pellets. On day 3 postop- 
eratively, turning in control animals was 77.3 + 9.5% 
(mean +_ S.E,M.) of baseline, whereas experimental 
animals turned at a rate that was only 32.0 _+ 8.1% of 
baseline (baseline = 100%). 
By 10 days postoperatively the rate of turning had 
stabilized in both experimental and control animals, but 
rats with DA-releasing pellets showed a greater reduction 
in turning behavior than did control animals for the 
remainder of the experiment (P < 0.002). Animals with 
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Fig. 2. Mean (±  S.E.M.)  APO- induced  rotational behavior at 10, 
30 and 60 days post implantat ion in control animals (open bars: 
n = 9) and animals that received DA-rclcasing pellets (solid bars: 
n = 10) in the DA-denerva ted  str iatum. Rotational behavior was 
induced by A P O  (0.25 mg/kg) and is expressed as a percent  of the 
mean  rate of turning prior to implantat ion of the silicone polymer 
pellets. Prior to implantat ion of the pellets animals made 253.4 +_ 
31.6 full rotations/40-min test session (mean +_ S.E.M.) .  The rate of 
turning 10-60 days post implantat ion was significantly different from 
baseline in animals that received DA-releas ing pellets (P < (l.()()7, 
t-tests), but not in control animals.  The asterisks indicate that 
animals with the DA-releas ing pellets turned significantly less than 
did the control animals,  as indicated by a significant main effect of 
group (F~. w = 13.92; P < 0.002) but no effect of time (F - 0.8) or 
group by time interaction (F 0.1; 2-way A N O V A  with repeated 
measures) .  
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Fig. 3. Correlation between the distance from the ventricle of 
DA-releasing silicone polymer implants and the percent reduction 
in rotational behavior. Each data point represents one individual 
animal. Pellets placed close to the ventricle within the striatum were 
most effective in producing a reduction in APO-induced rotational 
behavior. 
Fig. 4. Cresyl violet-stained section (40 pm tick) of striatum adjacent 
to the site of a DA-silicone polymer pellet (initial negative 
enlargement x 50). * Indicates the site where the pellet was found 
in the striatum. Note the thin layer of fibrous appearing material 
and gliosis immediately adjacent to the cavity formed by the pellet, 
but the normal appearance of the striatal neurons within a few 
microns of the implant site. 
DA-si l icone pellets turned at a rate that was less than 
50% of baseline when animals were tested at 30 and 60 
days after implantation (Fig. 2). In contrast, between 10 
and 60 days postoperatively the rate of turning in control 
animals was not significantly different from baseline. 
Interestingly, the location of the pellet within the 
striatum was a significant factor in how effectively the 
implant reduced rotational behavior (Fig. 3). The more 
lateral the placement the smaller the decrease in rota- 
tional behavior (r = 0.693, P = 0.001). This finding is 
similar to that described by Dunnet t  and colleagues using 
fetal substantia nigra grafts transplanted into striatum 7~. 
It should also be noted that in two animals the pellet was 
inadvertently positioned within the ventricle and in these 
animals rotational behavior was not reduced (data not 
shown). 
Examination of the histology showed that there were 
no gross tissue compatibility problems with this polymer 
matrix. There was a thin layer of fibrous tissue and gliosis 
immediately adjacent to the site of implant, but normal 
appearing neurons within a few microns of  the implant 
cavity (Fig. 4). This was expected because the silicone 
polymer has received F D A  approval for biomedical 
applications. Similar tissue compatibility has been re- 
cently reported following implantation of polyvinyt 
acrylic copolymer capsules into neocortex 1"2°. 
DISCUSSION 
Implantation of a silicone polymer pellet that released 
D A  into the denervated striatum reduced the behavioral 
asymmetry associated with unilateral nigrostriatal D A  
depletion. While a transient reduction in rotational 
behavior was observed in control animals (probably due 
to non-specific trauma associated with the surgery) 
turning rates had returned to preimplant levels by day 10. 
In contrast, animals with DA-releasing implants showed 
a significantly greater decrease in turning at 3 days 
postimplant, than did animals with control implants, and 
continued to exhibit reduced rotational behavior for 2 
months. Exactly how long the pellets would continue to 
be effective in vivo remains to be determined, 
The magnitude of the decrease in the APO-st imulated 
rotational behavior seen here is comparable to that 
obtained with other procedures. For example, a 25-50% 
reduction in APO-induced  rotation is seen with adrenal 
medulla grafts 9"]1'17, or with the intrastriatal infusion of 
DA (0.5-5 /*g/h) using an osmotic mini-pump for two 
weeks (ref. 13; see also ref. 17). In the present study, in 
vitro release from the pellets decreased from 385 to 16 
pg/h (or from 150.8 to 6.3 fmol/min) between days 10 and 
56. Whereas this rate of  D A  release is very low, it is 
within the range of  normal extracellular DA-release rates 
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repor ted  in microdialysis  studies 16 and the behavioral  
evidence indicates that  release was sufficient to maintain 
suppression of ro ta t ional  behavior  by 50%. It is also 
re levant  that  D A  diffuses quite freely through a D A -  
dep le ted  str iatum, unlike the intact s tr iatum where 
diffusion is p reven ted  by re-uptake  into presynapt ic  D A  
terminals  5. It should be noted,  that the rate of D A  
release during this t ime per iod  was declining gradually 
and that  in vitro exper iments  at best  provide only a rough 
es t imate  of release rate in vivo. However ,  previous work 
by others  has demons t ra ted  that there is a close corre- 
spondence  be tween  in vitro and in vivo drug release with 
some po lymer  matrix systems ~. Nevertheless ,  further  
exper iments  will be required to de termine  the in vivo rate 
of D A  release from the type of silicone po lymer  pellets 
used here.  
Al though the magni tude of the reduction in APO-  
induced ro ta t ional  behavior  seen here was close to that 
seen with adrenal  medul la  grafts it is not known whether  
this represents  the maximal  effect possible using this 
procedure .  It may be,  for example ,  that the silicone 
po lymer  pellets were not opt imal ly  placed in the str iatum 
for reducing rotat ional  behavior ,  or that the dose was 
subopt imal .  Whe the r  o ther  sites within the str iatum may 
be more  effective is current ly  under  investigation, as are 
d o s e - r e s p o n s e  studies. 
In conclusion,  this pre l iminary  study demonst ra tes  that 
it is possible to produce  a sustained reduct ion in the 
symptoms associated with striatal D A  deplet ion by 
chronic implanta t ion  of an exogenous source of D A ,  such 
as the contro l led  release D A - s i l i c o n e  po lymer  matrix 
pellet  used here.  This supports  the idea that  in some 
neural  systems grafts may only need to provide  a tonic, 
unregula ted  source of neuro t ransmi t te r  to be effective; 
i .e. integrat ion of the graft and host is not necessary 2. Of 
course,  many more  exper iments  will be required to 
thoroughly evaluate  the technique descr ibed here.  For 
example ,  addi t ional  exper iments  will be required to 
de te rmine  the extent  and rate of D A  diffusion in vivo as 
well as the long-term stabili ty of D A  within the silicone 
po lymer  matrix.  In addi t ion,  the po lymer  used was not 
ideal because release was cont inuously decreasing over 
time. Polymers from which release occurs at a constant  
rate (i.e. ze ro-order  release kinetics) may be more 
beneficial .  We are current ly exper iment ing  with the use 
of rate- l imit ing membranes  ~2 to achieve zero-order  re- 
lease kinetics from po lymer  matrices of this type. Even 
more impor tant  to possible clinical applicat ions,  the 
ability of DA-re leas ing  pellets to al leviate o ther  behav- 
ioral symptoms of striatal D A  deplet ion must be 
thoroughly evaluated  (especially following bilateral  
insult). Nevertheless ,  the exper iment  repor ted  here 
suggests this approach could potent ia l ly  provide an 
al ternat ive to tissue grafts in the t rea tment  of Parkinson 's  
Disease.  
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